Literature DB >> 11973226

Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery.

Wulf Dietrich, Michael Spannagl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11973226     DOI： 10.1097/00000539-200205000-00070

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  7 in total

Review 1.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

2.  Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome?

Authors:  Giovanni Saeed; George Ganster; Norbert Friedel
Journal:  Tex Heart Inst J       Date:  2008

3.  Recombinant factor VII is associated with worse survival in complex cardiac surgical patients.

Authors:  Andrej Alfirevic; Andra Duncan; Jing You; Cheryl Lober; Edward Soltesz
Journal:  Ann Thorac Surg       Date:  2014-06-24       Impact factor: 4.330

4.  Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.

Authors:  Yoan Lamarche; Philippe Demers; Nancy C Poirier; Danielle Robitaille; Raymond Cartier
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

Review 5.  Pharmacology and clinical use of recombinant activated factor seven in neurosciences.

Authors:  Matthias Hartmann; Christoph Sucker
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

6.  Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.

Authors:  Manish J Gandhi; Richard A Pierce; Lini Zhang; Marc R Moon; George J Despotis; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-07-06       Impact factor: 1.637

7.  Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.

Authors:  Wen Yan; Chengluan Xuan; Guojia Ma; Liang Zhang; Ning Dong; Zijian Wang; Rihao Xu
Journal:  J Cardiothorac Surg       Date:  2014-09-02       Impact factor: 1.637
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.